Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-7479d7b7d-fwgfc Total loading time: 0 Render date: 2024-07-11T15:26:21.790Z Has data issue: false hasContentIssue false

79 - Cannabinoids in Dystonias

from Section X - Emerging Therapies for Dystonia

Published online by Cambridge University Press:  31 May 2018

By
Eckart Altenmüller  and
Andrè Lee
Edited by
Dirk Dressler ,
Eckart Altenmüller  and
Joachim K. Krauss
Dirk Dressler
Affiliation:
Hannover Medical School
Eckart Altenmüller
Affiliation:
Hochschule für Musik, Theater und Medien, Hannover
Joachim K. Krauss
Affiliation:
Hannover Medical School
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Treatment of Dystonia , pp. 420 - 424
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Altenmüller, E, Jabusch, H-C (2010) Focal dystonia in musicians: phenomenology, pathophysiology, triggering factors, and treatment. Med Probl Perform Art 25:3–9.CrossRefGoogle ScholarPubMed
Argyelan, M, Carbon, M, Niethammer, M, Ulug, AM, Voss, HU, Bressman, SB, Dhawan, V, Eidelberg, D (2009) Cerebellothalamocortical connectivity regulates penetrance in dystonia. J Neurosci 29:9740–9747.CrossRefGoogle ScholarPubMed
Berardelli, A (1998) The pathophysiology of primary dystonia. Brain 121:1195–1212.CrossRefGoogle ScholarPubMed
Borgelt, LM, Franson, KL, Nussbaum, AM, Wang, GS (2013). The pharmacologic and clinical effects of medical cannabis. Pharmacotherapy 33:195–209.CrossRefGoogle ScholarPubMed
Breakefield, XO, Blood, AJ, Li, Y, Hallett, M, Hanson, PI, Standaert, DG (2008) The pathophysiological basis of dystonias. Nat Rev Neurosci 9:222–234.CrossRefGoogle ScholarPubMed
Chatterjee, A, Almahrezi, A, Ware, M, Fitzcharles, MA (2002) A dramatic response to inhaled cannabis in a woman with central thalamic pain and dystonia. J Pain Symptom Manage 24:4–6.CrossRefGoogle Scholar
Compton, DR, Aceto, MD, Lowe, J, Martin, BR (1996) In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity. J Pharmacol Exp Ther 277:586–594.Google Scholar
Consroe, P, Sandyk, R, Snider, SR (1986). Open label evaluation of cannabidiol in dystonic movement disorders. Int J Neurosci 30:277–282.Google Scholar
Fox, SH, Kellett, M, Moore, AP, Crossman, AR, Brotchie, JM (2002) Randomised, double-blind, placebo-controlled trial to assess the potential of cannabinoid receptor stimulation in the treatment of dystonia. Mov Disord 17:145–149.CrossRefGoogle ScholarPubMed
Gauter, B, Rukwied, R, Konrad, C (2004) Cannabinoid agonists in the treatment of blepharospasm: a case report study. Neuro Endocrinol Lett 25:45–48.Google Scholar
Haberstick, BC, Young, SE, Zeiger, JS, Lessem, JM, Hewitt, JK, Hopfer, CJ (2014) Prevalence and correlates of alcohol and cannabis use disorders in the United States: results from the national longitudinal study of adolescent health. Drug Alcohol Depend 136:158–161.CrossRefGoogle ScholarPubMed
Hallett, M (2006) Pathophysiology of writer’s cramp. Hum Mov Sci 25:454–463.CrossRefGoogle ScholarPubMed
Hallett, M (2011) Neurophysiology of dystonia: the role of inhibition. Neurobiol Dis 42:177–184.Google Scholar
Herkenham, M, Lynn, AB, Johnson, MR, Melvin, LS, de Costa, BR, Rice, KC (1991) Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 11:563–583.Google Scholar
Iversen, L (2003) Cannabis and the brain. Brain J Neurol 126:1252–1270.Google Scholar
Jabusch, H-C, Schneider, U, Altenmüller, E (2004) Delta9-tetrahydrocannabinol improves motor control in a patient with musician’s dystonia. Mov Disord 19:990–991.CrossRefGoogle Scholar
Kluger, B, Triolo, P, Jones, W, Jankovic, J (2015) The therapeutic potential of cannabinoids for movement disorders. Mov Disord 30:313–327.CrossRefGoogle ScholarPubMed
Koppel, BS, Brust, JC, Fife, T, Bronstein, J, Youssof, S, Gronseth, G, Gloss, D (2014) Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders – report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 82:1556–1563.CrossRefGoogle Scholar
Kreitzer, AC, Regehr, WG (2001) Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron 29:717–727.Google Scholar
Lile, JA, Kelly, TH, Charnigo, RJ, Stinchcomb, AL, Hays, LR (2013) Pharmacokinetic and pharmacodynamic profile of supratherapeutic oral doses of Delta(9)-THC in cannabis users. J Clin Pharmacol 53:680–690.Google Scholar
Llano, I, Leresche, N, Marty, A (1991) Calcium entry increases the sensitivity of cerebellar Purkinje cells to applied GABA and decreases inhibitory synaptic currents. Neuron 6:565–574.Google Scholar
Martinasek, MP, McGrogan, JB, Maysonet, A (2016) A systematic review of the respiratory effects of inhalational marijuana. Respir Care 61:1543–1551.Google Scholar
Matsuda, LA, Bonner, TI, Lolait, SJ (1993) Localization of cannabinoid receptor mRNA in rat brain. J Comp Neurol 327:535–550.Google Scholar
Moreira, FA, Grieb, M, Lutz, B (2009) Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression. Best Pract Res Clin Endocrinol Metab 23:133–144.Google Scholar
Müller-Vahl, KR, Prevedel, H, Theloe, K, Kolbe, H, Emrich, HM, Schneider, U (2003) Treatment of Tourette syndrome with delta-9-tetrahydrocannabinol (delta 9-THC): no influence on neuropsychological performance. Neuropsychopharmacol 28:384–388.CrossRefGoogle ScholarPubMed
Neychev, VK, Fan, X, Mitev, VI, Hess, EJ, Jinnah, HA (2008) The basal ganglia and cerebellum interact in the expression of dystonic movement. Brain 131:2499–2509.CrossRefGoogle ScholarPubMed
Pitler, TA, Alger, BE (1992) Postsynaptic spike firing reduces synaptic GABAA responses in hippocampal pyramidal cells. J Neurosci 12:4122–4132.CrossRefGoogle ScholarPubMed
Richter, A, Löscher, W (1994) (+)-WIN 55,212-2, a novel cannabinoid receptor agonist, exerts antidystonic effects in mutant dystonic hamsters. Eur J Pharmacol 264:371–377.CrossRefGoogle ScholarPubMed
Richter, A, Löscher, W (2002) Effects of pharmacological manipulations of cannabinoid receptors on severity of dystonia in a genetic model of paroxysmal dyskinesia. Eur J Pharmacol 454:145–151.Google Scholar
Richter, L, Pugh, BS, Ball, SA (2016) Assessing the risk of marijuana use disorder among adolescents and adults who use marijuana. Am J Drug Alcohol Abuse 13:1–14.Google Scholar
Riedel, G, Davies, SN (2005) Cannabinoid function in learning, memory and plasticity. Handb Exp Pharmacol 168:445–477.Google Scholar
Russo, E, Guy, GW (2006) A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol. Med Hypotheses 66:234–246.Google Scholar
Sañudo-Peña, MC, Patrick, SL, Khen, S, Patrick, RL, Tsou, K, Walker, JM (1998) Cannabinoid effects in basal ganglia in a rat model of Parkinson’s disease. Neurosci Lett 248:171–174.Google Scholar
Secades-Villa, R, Garcia-Rodriguez, O, Jin, CJ, Wang, S, Blanco, C (2014) Probability and predictors of the cannabis gateway effect: a national study. Int J Drug Policy 26:135–142.Google Scholar
Trigo, JM, Lagzdins, D, Rehm, J, Selby, P, Gamaleddin, I, Fischer, B, Barnes, AJ, Huestis, MA, Le Foll, B (2016) Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings. Drug Alcohol Depend 161:298–306.CrossRefGoogle ScholarPubMed
Uribe Roca, MC, Micheli, F, Viotti, R (2005) Cannabis sativa and dystonia secondary to Wilson’s disease. Mov Disord 20:113–115.Google Scholar
Volkow, ND, Baler, RD, Compton, WM, Weiss, SR (2014a) Adverse health effects of marijuana use. N Engl J Med 370:2219–2227.CrossRefGoogle ScholarPubMed
Volkow, ND, Wang, GJ, Telang, F, Fowler, JS, Alexoff, D, Logan, J, Jayne, M, Wong, C, Tomasi, D (2014b) Decreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severity. Proc Natl Acad Sci 111:3149–3156.CrossRefGoogle ScholarPubMed
Warner, LA, Kessler, RC, Hughes, M, Anthony, JC, Nelson, CB (1995) Prevalence and correlates of drug use and dependence in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 52:219–229.CrossRefGoogle ScholarPubMed
Zadikoff, C, Wadia, PM, Miyasaki, JM, Chen, R, Lang, AE, So, J, Fox, SH (2011) Cannabinoid, CB1 agonists in cervical dystonia: failure in a phase IIa randomized controlled trial. Basal Ganglia 1:91–95.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×